Edition:
India

GlaxoSmithKline PLC (GSK.L)

GSK.L on London Stock Exchange

1,563.80GBp
18 Jul 2018
Change (% chg)

2.80 (+0.18%)
Prev Close
1,561.00
Open
1,572.20
Day's High
1,591.20
Day's Low
1,563.00
Volume
7,967,716
Avg. Vol
8,751,658
52-wk High
1,632.00
52-wk Low
1,235.20

Chart for

About

GlaxoSmithKline plc is a global healthcare company. The Company operates through three segments: Pharmaceuticals, Vaccines and Consumer Healthcare. The Company focuses on its research across six areas: Respiratory diseases, human immunodeficiency virus (HIV)/infectious diseases, Vaccines, Immuno-inflammation, Oncology and Rare... (more)

Overall

Beta: 1.21
Market Cap(Mil.): £75,181.28
Shares Outstanding(Mil.): 4,918.63
Dividend: 19.00
Yield (%): --

Financials

  GSK.L Industry Sector
P/E (TTM): 38.75 30.93 32.76
EPS (TTM): 0.39 -- --
ROI: 7.58 15.07 14.61
ROE: 278.84 16.60 16.34

Clamor for GSK shingles shot points to bigger profits

LONDON GlaxoSmithKline is facing "unprecedented" demand for its new shingles vaccine Shingrix, suggesting the product could be a bigger money-spinner than the company and analysts initially thought.

25 Jun 2018

Clamour for GSK shingles shot points to bigger profits

* Strong demand will mean intermittent shortages through 2018

25 Jun 2018

GSK takes billion-dollar drug fight with Gilead to top AIDS meeting

LONDON, June 20 GlaxoSmithKline is taking its fight with Gilead Sciences for dominance of the HIV market to the world's leading AIDS conference next month by showcasing detailed results from its new two-drug treatment.

20 Jun 2018

Kraft Heinz considering sale of Complan brand in India - Bloomberg

Kraft Heinz Co is considering a sale of children's energy drink brand Complan in India, which could fetch about $1 billion, Bloomberg reported on Monday, citing people familiar with the matter.

18 Jun 2018

Kraft Heinz considering sale of Complan brand in India: Bloomberg

Kraft Heinz Co is considering a sale of children's energy drink brand Complan in India, which could fetch about $1 billion, Bloomberg reported on Monday, citing people familiar with the matter.

18 Jun 2018

Kraft Heinz considering sale of Complan brand in India - Bbg

June 18 Kraft Heinz Co is considering a sale of children's energy drink brand Complan in India, which could fetch about $1 billion, Bloomberg reported on Monday, citing people familiar with the matter.

18 Jun 2018

GSK's two-drug HIV treatment meets main goal in late stage studies

GlaxoSmithKline's two-drug treatment for HIV, the virus that causes AIDS, met its main goal in late stage studies, scoring key points in its rivalry with Gilead in the medical field.

14 Jun 2018

CORRECTED-UPDATE 1-GSK's two-drug HIV treatment meets main goal in late stage studies

June 14 GlaxoSmithKline said on Thursday that its two-drug treatment for HIV, the virus that causes AIDS, met its main goal in late stage studies - a big win after regulators warned of possible birth defects from one of the two drugs.

14 Jun 2018

CORRECTED-GSK's two-drug HIV treatment meets main goal in late stage studies

June 14 GlaxoSmithKline said on Thursday that its two-drug treatment for HIV, the virus that causes AIDS, met its main goal in late stage studies.

14 Jun 2018

FDA finds deficiencies in Mylan's generic Advair; shares fall

Mylan NV said on Wednesday that U.S. health regulators were unable to approve its generic version of GlaxoSmithKline's blockbuster inhaled lung drug Advair for the second time, as they found "minor deficiencies" in the treatment.

14 Jun 2018

Earnings vs. Estimates